YWX-15839-47798

Timeline

1. 2021-03-16
   Dose 1 — Pfizer-BioNTech
2. 2021-04-06
   Dose 2 — Pfizer-BioNTech
3. 2021-04-07
   Registered in v-safe
4. 2021-05-07
   Survey response — day 28, dose 2

   MedDRA: Headache, Migraine, Migraine with aura — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

   Free text: Migraine and/or headache lasting over 4 weeks now with and without auras

   MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
5. 2021-05-07
   Report sent to call center — day 28, dose 2

   Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

   1 call case(s)
6. 2021-05-11
   Survey response — day 35, dose 2

   MedDRA: Dehydration, Fatigue, Ophthalmic migraine, Pollakiuria — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

   Free text: Another Severe ocular migraine, dehydration, fatigue, increased urination

   MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
7. 2021-05-11
   Report sent to call center — day 35, dose 2

   Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

   1 call case(s)
8. 2021-05-20
   Health check-in — day 42, dose 2

   Feeling: Poor

   Adult check-in
9. 2021-07-07
   Health check-in — 3 months, dose 2

   Feeling: Fair

   Adult check-in
10. 2021-10-05
    Survey response — 6 months, dose 2

    MedDRA: Migraine, Nervous system disorder, Postural orthostatic tachycardia syndrome — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

    Free text: continuing treatment resistant severe migraine and POTS attacks plus associated neurological issues for 6 months now. Appear to be improving periodically for last couple of months, but debilitating relapses keep persisting, not at baseline yet

    MedDRA releases: 2024-11 · check-in free text available
11. 2021-10-05
    Report sent to call center — 6 months, dose 2

    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
12. 2021-10-06
    Call 1 — Left Voicemail
13. 2021-12-03
    Call successful

    Participant prefers to complete VAERS report online
14. 2022-04-06
    Survey response — 12 months, dose 2

    MedDRA: Autonomic nervous system imbalance, Chest pain, Migraine, Neuropathy peripheral, Paraesthesia, Postural orthostatic tachycardia syndrome, Tachycardia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit

    Free text: Continuing to have episodes of severe migraines, neuropathy and POTS, dysautonomia, tachycardia, internal vibrations, chest pain etc

    MedDRA releases: 2024-11 · check-in free text available
15. 2022-04-06
    Report sent to call center — 12 months, dose 2

    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

    Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
16. 2022-04-11
    Call 1 — Left Voicemail
17. 2022-05-17
    Call successful

    Participant prefers to complete VAERS report online